Cabaletta Bio Inc
(NASDAQ:CABA)
$15.92
-0.31[-1.91%]
Last update: 5:06PM (Delayed 15-Minutes)
Get Real Time Here
$15.92
0[0.00%]
After-Hours
Open-Close-
Vol / Avg.87.000 / 1.125MMkt Cap682.163M
Day Range- - -52 Wk Range5.120 - 19.340

Cabaletta Bio Stock (NASDAQ:CABA), Analyst Ratings, Price Targets, Predictions

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.

Consensus Rating1

Buy

Highest Price Target1

$50.00

Lowest Price Target1

$10.00

Consensus Price Target1

$24.82

Analyst Rating Summary1

BuyOverweightHoldUnderweightSell
74000

Analyst Firms Making Recommendations1

  • Morgan Stanley
  • HC Wainwright & Co.
  • Cantor Fitzgerald
  • Stifel
  • Wells Fargo

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Cabaletta Bio

Upgrades (1)

Downgrades (1)

Initiations (7)

date
ticker
Buy Now
Company
Current price
Upside/Downside
Analyst Firm
Analyst & % Accurate
Price Target Change
Rating Change
Previous / Current Rating
Get Alert
11/29/2023CABABuy Now
Cabaletta Bio
$15.9257.04%Morgan Stanley
Michael Ulz
$28 → $25MaintainsOverweightGet Alert
11/29/2023CABABuy Now
Cabaletta Bio
$15.9257.04%HC Wainwright & Co.
Douglas Tsao
→ $25ReiteratesBuy → BuyGet Alert
11/15/2023CABABuy Now
Cabaletta Bio
$15.92214.07%Cantor Fitzgerald
Joshua Schimmer
$40 → $50MaintainsOverweightGet Alert
11/10/2023CABABuy Now
Cabaletta Bio
$15.9257.04%HC Wainwright & Co.
Douglas Tsao
$17 → $25MaintainsBuyGet Alert
11/08/2023CABABuy Now
Cabaletta Bio
$15.9275.88%Morgan Stanley
Michael Ulz
$16 → $28MaintainsOverweightGet Alert
10/24/2023CABABuy Now
Cabaletta Bio
$15.92151.26%Cantor Fitzgerald
Joshua Schimmer
→ $40Initiates → OverweightGet Alert
10/19/2023CABABuy Now
Cabaletta Bio
$15.9294.72%Stifel
Ben Burnett
→ $31Initiates → BuyGet Alert
10/04/2023CABABuy Now
Cabaletta Bio
$15.926.78%HC Wainwright & Co.
Douglas Tsao
→ $17ReiteratesBuy → BuyGet Alert
09/18/2023CABABuy Now
Cabaletta Bio
$15.92144.97%Wells Fargo
Derek Archila
$14 → $39MaintainsOverweightGet Alert
09/05/2023CABABuy Now
Cabaletta Bio
$15.9238.19%Citigroup
Samantha Semenkow
→ $22Initiates → BuyGet Alert
08/14/2023CABABuy Now
Cabaletta Bio
$15.92113.57%Guggenheim
Yatin Suneja
→ $34ReiteratesBuy → BuyGet Alert
08/11/2023CABABuy Now
Cabaletta Bio
$15.926.78%HC Wainwright & Co.
Douglas Tsao
$15 → $17MaintainsBuyGet Alert
07/18/2023CABABuy Now
Cabaletta Bio
$15.92113.57%Guggenheim
Yatin Suneja
→ $34Initiates → BuyGet Alert
05/17/2023CABABuy Now
Cabaletta Bio
$15.92-5.78%HC Wainwright & Co.
Douglas Tsao
→ $15ReiteratesBuy → BuyGet Alert
05/12/2023CABABuy Now
Cabaletta Bio
$15.92-5.78%HC Wainwright & Co.
Douglas Tsao
→ $15ReiteratesBuy → BuyGet Alert
05/03/2023CABABuy Now
Cabaletta Bio
$15.92-5.78%HC Wainwright & Co.
Douglas Tsao
→ $15Reiterates → BuyGet Alert
04/10/2023CABABuy Now
Cabaletta Bio
$15.92-5.78%HC Wainwright & Co.
Douglas Tsao
→ $15Reiterates → BuyGet Alert
04/03/2023CABABuy Now
Cabaletta Bio
$15.92-5.78%HC Wainwright & Co.
Douglas Tsao
→ $15Reiterates → BuyGet Alert
03/22/2023CABABuy Now
Cabaletta Bio
$15.92-24.62%Chardan Capital
Geulah Livshits
→ $12Reiterates → BuyGet Alert
Q

What is the target price for Cabaletta Bio (CABA)?

A

The latest price target for Cabaletta Bio (NASDAQ: CABA) was reported by Morgan Stanley on November 29, 2023. The analyst firm set a price target for $25.00 expecting CABA to rise to within 12 months (a possible 57.04% upside). 24 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Cabaletta Bio (CABA)?

A

The latest analyst rating for Cabaletta Bio (NASDAQ: CABA) was provided by Morgan Stanley, and Cabaletta Bio maintained their overweight rating.

Q

When is the next analyst rating going to be posted or updated for Cabaletta Bio (CABA)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Cabaletta Bio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Cabaletta Bio was filed on November 29, 2023 so you should expect the next rating to be made available sometime around November 29, 2024.

Q

Is the Analyst Rating Cabaletta Bio (CABA) correct?

A

While ratings are subjective and will change, the latest Cabaletta Bio (CABA) rating was a maintained with a price target of $28.00 to $25.00. The current price Cabaletta Bio (CABA) is trading at is $15.92, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.